Hamburg Wants Predictability In FDA Funding, Ability To Access Sequestered User Fees
This article was originally published in The Gray Sheet
Executive Summary
FDA commissioner says the agency cannot operate effectively without predictable budgets and that sequestering user fees needs to end.
You may also be interested in...
News Briefs: Senate Introduces User Fee Bill; Lawsuit Ends Over Conflict Minerals
Senators try to shield FDA user fees from sequestration. Court rejects business groups’ challenge to conflict minerals reporting law. More news in brief
House Plan Includes No Increase For CDRH In 2014; User Fee Sequester Unresolved
A House subcommittee passed an appropriations package last week that would keep FDA device funding levels flat in fiscal 2014. The package would increase appropriations to FDA as a whole compared to 2013, but it falls short of the President’s budget request, and leaves unresolved whether 2014 user fees would be sequestered.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.